Organisation paid for research Program year 2023 Source: CMS Open Payments

A and R Research Group LLC

Neither a doctor nor a teaching hospital

Research payments

$28,124

29 payments

Through program year 2023, A and R Research Group LLC is reported as receiving $28,124 in research payments, across 29 payments.

By program year

2 rows
Year Kind Amount Payments
2023 Research $2,700 2
2021 Research $25,424 27

Breakdown

Who paid Research payments · program years 2021–2023
  1. Boehringer Ingelheim Canada Ltd.Ltee $13,024 24 payments
  2. Chiesi USA, Inc. $9,700 4 payments
  3. Boehringer Ingelheim Pharmaceuticals, Inc. $5,400 1 payment
Studies the money was for Research payments · program years 2021–2023
  1. BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV $13,024 24 payments
  2. BI 767551 EX14870 Ph II III SARS COV 2 Ambulato $5,400 1 payment
  3. A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp 500g) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) (PILLAR) $2,700 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record